Adma Biologics (ADMA) Goodwill & Intangibles (2017 - 2025)

Adma Biologics' Goodwill & Intangibles history runs 9 years deep, the most recent figure standing at $4.1 million for Q4 2025.

• Quarterly Goodwill & Intangibles rose 3.56% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (up 3.56% YoY) and the FY2025 annual result came in at $4.1 million, up 3.56% from the prior year.
• Goodwill & Intangibles was $4.1 million for Q4 2025 at Adma Biologics, up from $4.0 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $9.6 million in Q1 2021 and bottomed at $3.9 million in Q1 2024.
• A 5-year average of $5.5 million and a median of $4.3 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles surged 115.81% — and 2025, when it slumped 55.41%.
• Adma Biologics' Goodwill & Intangibles stood at $5.3 million in 2021, then dropped by 14.17% to $4.5 million in 2022, then slipped by 10.72% to $4.0 million in 2023, then dropped by 0.97% to $4.0 million in 2024, then grew by 3.56% to $4.1 million in 2025.
• Business Quant data shows ADMA's Goodwill & Intangibles at $4.1 million in Q4 2025, $4.0 million in Q3 2025, and $4.0 million in Q2 2025.